Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ellingsen Medicinkonsult AB
AB
Active
Org 5592704349
Sysslomansgatan 15 B, 753 14
Uppsala
Other education n.e.c.
· NACE 8559
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other education n.e.c.
/
Ellingsen Medicinkonsult AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
76
77
75
81
47
Staff expenses
—
−3
−3
−1
−5
EBITDA
42
60
66
75
36
Depreciation & amort.
−0
—
—
—
—
EBIT
42
60
66
75
36
Net financials
—
0
0
0
0
Profit before tax
42
60
66
75
36
Tax
−9
−12
−14
−16
−8
Net profit
33
48
52
59
29
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
79
116
121
125
77
Equity
58
85
88
97
66
Long-term debt
0
—
—
—
—
Short-term debt
21
30
33
28
11
Total debt
21
30
33
28
11
Financial ratios
5-year trend
EBITDA margin
76.5%
This company
15.8%
Market median
+384% vs market
2021
2025
Equity ratio
85.5%
This company
38.2%
Market median
+124% vs market
2021
2025
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
2021
2025
Net profit margin
60.5%
This company
8.1%
Market median
+647% vs market
2021
2025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
2021
2025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
View
PDF
More on Ellingsen Medicinkonsult AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
